Russian University First To Complete Human Trials of World’s First COVID-19 Vaccine
GUWAHATI: Russia has emerged as the first country to have successfully completed human trials of the world’s first coronavirus vaccine at Sechenov First Moscow State Medical University.
The purpose of the trial was to study whether the vaccine is safe for human health which showed positive results, said Alexander Lukashev, Director of the Institute of Medical Parasitology, Tropical and Vector-Borne Diseases of Sechenov University.
"The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market," Lukashev told a Russian News Agency.
Further, their vaccine development plan is also being determined by the developer, including the complexity of the epidemiological situation with the virus and the possibility of scaling up the production of the vaccine.